In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Opiranserin Hydrochloride Drug Master File in Korea (Opiranserin Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Opiranserin Hydrochloride. The MFDS reviews the Opiranserin Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Opiranserin Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Opiranserin Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Opiranserin Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Opiranserin Hydrochloride suppliers with KDMF on PharmaCompass.